Invention Grant
![Amide substituted imidazo[4,5-C]quinoline compounds with a branched chain linking group for use as an immune response modifier](/docs/US/2022-04-19/US11306083B2/abs.jpg.600x600.jpg)
- Patent Title: Amide substituted imidazo[4,5-C]quinoline compounds with a branched chain linking group for use as an immune response modifier
-
Application No.: US15733207Application Date: 2018-12-14
-
Publication No.: US11306083B2Publication Date: 2022-04-19
- Inventor: George W. Griesgraber
- Applicant: 3M INNOVATIVE PROPERTIES COMPANY
- Applicant Address: US MN St. Paul
- Assignee: 3M INNOVATIVE PROPERTIES COMPANY
- Current Assignee: 3M INNOVATIVE PROPERTIES COMPANY
- Current Assignee Address: US MN St. Paul
- Agent Jean A. Lown
- International Application: PCT/IB2018/060122 WO 20181214
- International Announcement: WO2019/123178 WO 20190627
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61K39/39
![Amide substituted imidazo[4,5-C]quinoline compounds with a branched chain linking group for use as an immune response modifier](/abs-image/US/2022/04/19/US11306083B2/abs.jpg.150x150.jpg)
Abstract:
Imidazo[4,5-c]quinoline compounds having an alkylamide substituent that is attached at the N-1 position by a branched chain linking group, single enantiomers of the compounds, pharmaceutical compositions containing the compounds, and methods of making the compounds are disclosed. Methods of use of the compounds as immune response modifiers, for inducing cytokine biosynthesis in humans and animals, and in the treatment of diseases including infectious and neoplastic diseases are also disclosed. Formula (I):
Public/Granted literature
Information query
